It can take months to determine who will respond to a specific cancer treatment. This is time that many patients and their families simply cannot afford. Acute myeloid leukemia is a deadly disease and as few as 15% of patients fighting relapsed/refractory AML respond to the current standard of care. Notable #CSO Joseph Wagner shares his thoughts about unmet medical needs for patients fighting cancer. #AcuteMyeloidLeukemia #AML #cancer
Well done team! This is great!
Congrats guys!
Semi-retired
4wI used to work on ETO.